March 21, 2019
January 14, 2019
In 2018 we have seen increased investments in Alzheimer's biomarkers and increased interest in prevention.
January 3, 2019
The ADDF's Diagnostics Accelerator is matching a $2.5 million research investment from The Association for Frontotemporal Degeneration to invest in biomarkers for frontotemporal dementia.
September 24, 2018
Researchers shared updates on their approaches to developing Alzheimer's treatments at our annual conference.
September 21, 2018
The conference, organized by the Alzheimer's Drug Discovery Foundation, focused on gene therapy and alternative modalities for neurodegenerative diseases, progress in developing novel drugs, as well as the need for new biomarkers.
July 17, 2018
Bill Gates and Leonard Lauder have announced Diagnostics Accelerator, an initiative to develop new biomarkers for early detection for Alzheimer's.